This site is intended for UK healthcare professionals only

Diabetes Professional Care
21-22 October 2025, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

Legal Notice

DIABETES PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR DIABETES PROFESSIONAL CARE CAN BE FOUND HERE.
 

Conference programme

Subpage Hero

     

Keynote Theatre
  1. Keynote Theatre
    National updates
    • Liver & Kidney
    Keynote Theatre
    Integrating liver health into diabetes care pathway- how Fibroscan® and non-invasive tools can change clinical practice
    • Clinical
    Keynote Theatre
    • Technology & Innovation
    Keynote Theatre
    Session sponsor, GlucoMen iCan CGM System: What is the role of CGM in T2DM?
    • Cardiovascular Professional Care
    Keynote Theatre
  2. Keynote Theatre
    Tackling residual CVD risk in a primary care CVRM clinic | This session is organised and funded by Recordati Pharmaceuticals Limited , intended for UK HCPs only
    • Clinical
    Keynote Theatre
    • Obesity, Nutrition and Lifestyle
    Keynote Theatre
  3. Keynote Theatre
    Self-management support in people with multiple long-term conditions (multimorbidity)
Theatre A
    • Treatment and Management
    Theatre A
    Complex cases in type 2 diabetes : when to manage, when to refer
    • Technology & Innovation
    Theatre A
    Making sense of the tech: supporting patients using diabetes technology in primary care
    • Treatment and Management
    Theatre A
    • Liver & Kidney
    Theatre A
    How to diagnose and manage chronic kidney disease | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
    • Treatment and Management
    Theatre A
    • Liver & Kidney
    Theatre A
  1. Theatre A
    CaReMe-O in primary care- is it really ‘out with old, in with the new’?
  2. Theatre A
Theatre B
    • Prevention and Diagnosis
    Theatre B
    • Obesity, Nutrition and Lifestyle
    Theatre B
    • Technology & Innovation
    Theatre B
    Partnering to improve access to Hybrid Closed Loop systems in the community
    • Clinical
    Theatre B
    • Obesity, Nutrition and Lifestyle
    Theatre B
    Why is weight management so difficult but still so important in diabetes management? Does anything help? Practical tips to support patient progress
    • Treatment and Management
    Theatre B
    • Treatment and Management
    Theatre B
    • Technology & Innovation
    Theatre B
    The application of precision health in cardiovascular disease management: To infinity and beyond
    • Obesity, Nutrition and Lifestyle
    Theatre B
Theatre C
  1. Theatre C
    • Technology & Innovation
    Theatre C
    Improving outcomes for people with type 1 diabetes: DAFNE – an evidenced based intervention
  2. Theatre C
    • Technology & Innovation
    Theatre C
    Technology in action: supporting young lives affected by diabetes
    • Obesity, Nutrition and Lifestyle
    Theatre C
    Every movement matters: the importance of the 24-hour movement behaviours in diabetes and cardiovascular disease management
    • Obesity, Nutrition and Lifestyle
    Theatre C
    • Treatment and Management
    Theatre C
  3. Theatre C
    • Obesity, Nutrition and Lifestyle
    Theatre C
    • Obesity, Nutrition and Lifestyle
    Theatre C
Cardiovascular Professional Care Theatre
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Integrating lifestyle into cardiometabolic pathways
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Understanding cardiopulmonary risk in COPD | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    • Clinical
    Cardiovascular Professional Care Theatre
  1. Cardiovascular Professional Care Theatre
  2. Cardiovascular Professional Care Theatre
    The role of the multi-disciplinary team in RAASi optimisation for cardiorenal protection | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Residual CV Risk – Using Triglycerides as a Marker | This session is organised and funded by Recordati Pharmaceuticals Limited
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Lipid management-keeping it simple
Keynote Theatre
    • Clinical
    Keynote Theatre
    • Technology & Innovation
    Keynote Theatre
    Session sponsor, GlucoMen iCan CGM System: How should we implement CGM across healthcare settings?
    • Obesity, Nutrition and Lifestyle
    Keynote Theatre
    • Liver & Kidney
    Keynote Theatre
    How to diagnose and manage chronic kidney disease | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
    • Cardiovascular Professional Care
    Keynote Theatre
    CVD prevention- state of the nation
    • Liver & Kidney
    Keynote Theatre
    • Technology & Innovation
    Keynote Theatre
    Diabetes technology: where are we now, where are we going, and how do we get there?
    • Technology & Innovation
    Keynote Theatre
    Practical application: using advanced technologies to support people living with diabetes
Theatre A
    • Clinical
    Theatre A
    • Treatment and Management
    Theatre A
    • Prevention and Diagnosis
    Theatre A
    Type 1 diabetes- diagnosis and beyond
    • Technology & Innovation
    Theatre A
    • Liver & Kidney
    Theatre A
    The Bidirectional Relationship Between Type 2 Diabetes and MASH
    • Liver & Kidney
    Theatre A
    The NHS Digital Weight Management Programme: expansion under the 10 Year Health Plan
    • Treatment and Management
    Theatre A
    • Cardiovascular Professional Care
    Theatre A
    Cardiovascular renal metabolic (CVRM)– the interplay between HCP, patient/carer and the voluntary sector
    • Treatment and Management
    Theatre A
    Problematic polypharmacy in diabetes: why deprescribing matters
Theatre B
    • Treatment and Management
    Theatre B
    • Technology & Innovation
    Theatre B
    AI in healthcare based on the 10-year plan
    • Treatment and Management
    Theatre B
    • Clinical
    Theatre B
    • Technology & Innovation
    Theatre B
    Inpatient use of diabetes technologies
    • Obesity, Nutrition and Lifestyle
    Theatre B
    Culturally adapted dietary approaches: practical strategies for diverse patient populations
    • Treatment and Management
    Theatre B
    Supply issues and management of this including cost effective use of medicines in particular use of biosimilars
    • Prevention and Diagnosis
    Theatre B
    Early onset Type 2 diabetes
Theatre C
    • Obesity, Nutrition and Lifestyle
    Theatre C
    First contact role in dietetics
  1. Theatre C
    • Treatment and Management
    Theatre C
    SHIFTing gears to improve driver health and road safety through collaboration.
    • Treatment and Management
    Theatre C
    Exercise and nutrition management of type 1
    • Treatment and Management
    Theatre C
    • Prevention and Diagnosis
    Theatre C
    • Treatment and Management
    Theatre C
    Autism and diabetes- unique challenges and solutions
    • Prevention and Diagnosis
    Theatre C
Cardiovascular Professional Care Theatre
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
  1. Cardiovascular Professional Care Theatre
    “Lipids: going beyond LDL-C” | This session is organised and funded by Recordati Pharmaceuticals Limited
  2. Cardiovascular Professional Care Theatre
    The role of the multi-disciplinary team in RAASi optimisation for cardiorenal protection | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Understanding cardiopulmonary risk in COPD | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre
    Heart failure in patients with fraility
    • Cardiovascular Professional Care
    Cardiovascular Professional Care Theatre

Partners

Education Partner

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner